These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 12039699)

  • 1. Agonistic and antagonistic properties of progesterone metabolites at the human mineralocorticoid receptor.
    Quinkler M; Meyer B; Bumke-Vogt C; Grossmann C; Gruber U; Oelkers W; Diederich S; Bahr V
    Eur J Endocrinol; 2002 Jun; 146(6):789-99. PubMed ID: 12039699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progesterone metabolism in the human kidney and inhibition of 11beta-hydroxysteroid dehydrogenase type 2 by progesterone and its metabolites.
    Quinkler M; Johanssen S; Grossmann C; Bähr V; Müller M; Oelkers W; Diederich S
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4165-71. PubMed ID: 10566667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzyme-mediated protection of the mineralocorticoid receptor against progesterone in the human kidney.
    Quinkler M; Johanssen S; Bumke-Vogt C; Oelkers W; Bähr V; Diederich S
    Mol Cell Endocrinol; 2001 Jan; 171(1-2):21-4. PubMed ID: 11165007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cysteines 849 and 942 of human mineralocorticoid receptor are crucial for steroid binding.
    Lupo B; Mesnier D; Auzou G
    Biochemistry; 1998 Sep; 37(35):12153-9. PubMed ID: 9724527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 11beta-hydroxyprogesterone acts as a mineralocorticoid agonist in stimulating Na+ absorption in mammalian principal cortical collecting duct cells.
    Rafestin-Oblin ME; Fagart J; Souque A; Seguin C; Bens M; Vandewalle A
    Mol Pharmacol; 2002 Dec; 62(6):1306-13. PubMed ID: 12435797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological profile of CS-3150, a novel, highly potent and selective non-steroidal mineralocorticoid receptor antagonist.
    Arai K; Homma T; Morikawa Y; Ubukata N; Tsuruoka H; Aoki K; Ishikawa H; Mizuno M; Sada T
    Eur J Pharmacol; 2015 Aug; 761():226-34. PubMed ID: 26073023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporine a and FK506 inhibit transcriptional activity of the human mineralocorticoid receptor: a cell-based model to investigate partial aldosterone resistance in kidney transplantation.
    Deppe CE; Heering PJ; Viengchareun S; Grabensee B; Farman N; Lombès M
    Endocrinology; 2002 May; 143(5):1932-41. PubMed ID: 11956176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biotransformation of the mineralocorticoid receptor antagonists spironolactone and canrenone by human CYP11B1 and CYP11B2: Characterization of the products and their influence on mineralocorticoid receptor transactivation.
    Schiffer L; Müller AR; Hobler A; Brixius-Anderko S; Zapp J; Hannemann F; Bernhardt R
    J Steroid Biochem Mol Biol; 2016 Oct; 163():68-76. PubMed ID: 27125452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Difference of in vivo and in vitro antimineralocorticoid potency of progesterone.
    Quinkler M; Diederich S
    Endocr Res; 2002 Nov; 28(4):465-70. PubMed ID: 12530650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonism in the human mineralocorticoid receptor.
    Fagart J; Wurtz JM; Souque A; Hellal-Levy C; Moras D; Rafestin-Oblin ME
    EMBO J; 1998 Jun; 17(12):3317-25. PubMed ID: 9628869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of hormone selectivity in glucocorticoid and mineralocorticoid receptors.
    Baker ME; Funder JW; Kattoula SR
    J Steroid Biochem Mol Biol; 2013 Sep; 137():57-70. PubMed ID: 23907018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of the N-terminal region of the human mineralocorticoid receptor hormone-binding domain in agonist and antagonist binding as revealed by a new monoclonal antibody.
    Jalaguier S; Lupo B; Hugon G; Rafestin-Oblin ME; Auzou G
    Biochem J; 1997 May; 324 ( Pt 1)(Pt 1):57-63. PubMed ID: 9164841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the zebrafish (Danio rerio) mineralocorticoid receptor.
    Pippal JB; Cheung CM; Yao YZ; Brennan FE; Fuller PJ
    Mol Cell Endocrinol; 2011 Jan; 332(1-2):58-66. PubMed ID: 20932876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single amino acid mutation of ala-773 in the mineralocorticoid receptor confers agonist properties to 11beta-substituted spirolactones.
    Auzou G; Fagart J; Souque A; Hellal-Lévy C; Wurtz JM; Moras D; Rafestin-Oblin ME
    Mol Pharmacol; 2000 Oct; 58(4):684-91. PubMed ID: 10999937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulfhydryl groups are involved in the binding of agonists and antagonists to the human mineralocorticoid receptor.
    Souque A; Fagart J; Couette B; Rafestin-Oblin ME
    J Steroid Biochem Mol Biol; 1996 Mar; 57(5-6):315-21. PubMed ID: 8639467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the progesterone receptor and progesterone- metabolising enzymes in the female and male human kidney.
    Bumke-Vogt C; Bähr V; Diederich S; Herrmann SM; Anagnostopoulos I; Oelkers W; Quinkler M
    J Endocrinol; 2002 Nov; 175(2):349-64. PubMed ID: 12429033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mineralocorticoid activity of progesterone derivatives depends on the nature of the C18 substituent.
    Souque A; Fagart J; Couette B; Davioud E; Sobrio F; Marquet A; Rafestin-Oblin ME
    Endocrinology; 1995 Dec; 136(12):5651-8. PubMed ID: 7588320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mineralocorticoid receptor discriminates aldosterone from glucocorticoids independently of the 11 beta-hydroxysteroid dehydrogenase.
    Lombes M; Kenouch S; Souque A; Farman N; Rafestin-Oblin ME
    Endocrinology; 1994 Sep; 135(3):834-40. PubMed ID: 8070376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folding requirements of the ligand-binding domain of the human mineralocorticoid receptor.
    Couette B; Jalaguier S; Hellal-Levy C; Lupo B; Fagart J; Auzou G; Rafestin-Oblin ME
    Mol Endocrinol; 1998 Jun; 12(6):855-63. PubMed ID: 9626661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the human mineralocorticoid receptor gene 5'-regulatory region: evidence for differential hormonal regulation of two alternative promoters via nonclassical mechanisms.
    Zennaro MC; Le Menuet D; Lombès M
    Mol Endocrinol; 1996 Dec; 10(12):1549-60. PubMed ID: 8961265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.